RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AKBA
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for Akebia Therapeutics stock price on Wednesday moving between $2.05 and $2.34
(Updated on Mar 27, 2024)

Buy or Hold candidate since Mar 15, 2024 Gain 31.76% PDF

The Akebia Therapeutics stock price gained 12.00% on the last trading day (Wednesday, 27th Mar 2024), rising from $2.00 to $2.24. During the last trading day the stock fluctuated 14.18% from a day low at $2.05 to a day high of $2.34. The price has risen in 7 of the last 10 days and is up by 58.87% over the past 2 weeks. Volume fell on the last day by -1 million shares and in total, 9 million shares were bought and sold for approximately $19.85 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock has broken the very wide and strong rising the short-term trend up and an even stronger rate of rising is indicated. For any reaction back there will now be support on the roof on the current trend broken at $2.07, a level that may pose a second chance to hit a runner. According to fan-theory $2.63 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

AKBA Signals & Forecast

Mostly positive signals in the chart today. The Akebia Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $2.06 and $1.64. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, February 23, 2024, and so far it has risen 65.93%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Akebia Therapeutics stock

On the downside, the stock finds support just below today's level from accumulated volume at $2.00 and $1.89. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Akebia Therapeutics finds support just below today's level at $2.00. If this is broken, then the next support from accumulated volume will be at $1.89 and $1.70.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.290 between high and low, or 14.18%. For the last week, the stock has had daily average volatility of 11.35%.

The Akebia Therapeutics stock is extremely overbought on RSI14 (76). Normally this may pose a good selling opportunity but since the stock has broken the trend up, the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken.

Our recommended stop-loss: $2.17 (-2.98%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 76 and this increases the risk substantially. There is a buy signal from a pivot bottom found 23 days ago.)

Trading Expectations (AKBA) For The Upcoming Trading Day Of Thursday 28th

For the upcoming trading day on Thursday, 28th we expect Akebia Therapeutics to open at $2.21, and during the day (based on 14 day Average True Range), to move between $2.06 and $2.42, which gives a possible trading interval of +/-$0.180 (+/-8.05%) up or down from last closing price. If Akebia Therapeutics takes out the full calculated possible swing range there will be an estimated 16.11% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $2.00, some $0.240 (10.71%) from the current price of $2.24, our system finds the risk reward attractive.

Is Akebia Therapeutics stock A Buy?

Several short-term signals are positive and the stock has broke the rising trend up, which indicates an even stronger rate of rising. We conclude that the current level may hold a buying opportunity as there is a fair chance for Akebia Therapeutics stock to perform well in the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.

Current score: 8.000 Strong Buy Candidate Upgraded

Predicted Opening Price for Akebia Therapeutics of Thursday, March 28, 2024

Fair opening price March 28, 2024 Current price
$2.21 ( 1.49%) $2.24

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for AKBA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.50 11.46 %
R2 2.39 6.51 %
R1 2.32 3.46 %
Current price: 2.24
Support S1 2.10 -6.43 %
S2 2.03 -9.49 %
S3 1.92 -14.43 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 2.24
Support S1 2.00 -10.71%
S2 1.89 -15.63%
S3 1.70 -24.11%

FAQ

What is the symbol for Akebia Therapeutics Stock and on which exchange is it traded?
The symbol for Akebia Therapeutics is AKBA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Akebia Therapeutics Stock?
Several short-term signals are positive and the stock has broke the rising trend up, which indicates an even stronger rate of rising. We conclude that the current level may hold a buying opportunity as there is a fair chance for Akebia Therapeutics stock to perform well in the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.

How to buy Akebia Therapeutics Stock?
Akebia Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Akebia Therapeutics Stock.

What's the current price of Akebia Therapeutics Stock?
As of the end of day on the 2024-03-27, the price of an Akebia Therapeutics (AKBA) share was $2.24.

What is the 52-week high and low for Akebia Therapeutics Stock?
The 52-week high for Akebia Therapeutics Stock is $2.34 and the 52-week low is $0.490.

What is the market capitalization of Akebia Therapeutics Stock?
As of the 2024-03-27, the market capitalization of Akebia Therapeutics is 418.744M.

When is the next earnings date for Akebia Therapeutics?
The upcoming earnings date for Akebia Therapeutics is May 13, 2024.
Click to get the best stock tips daily for free!

About Akebia Therapeutics

Akebia Therapeutics Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent adult patients. It also offers Auryxia, a ferric citra... AKBA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT